No Data
No Data
Why Applied DNA Sciences (APDN) Stock Is Rising
Applied DNA Sciences Shares Are Trading Higher After the Company Announced It Positioned Its TR8 PGx Testing as Pre-emptive Testing for Therapeutic Safety.
Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement
Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test
Trending Stocks Today | SAG Holdings Surges 60% Pre-Market
12 Health Care Stocks Moving In Wednesday's After-Market Session